Cellular Scent of Influenza Virus Infection

Overview

Journal Chembiochem

Specialty Biochemistry

Date 2014 Apr 11

PMID 24719290

Citations 47

Authors

Alexander A Aksenov

Christian E Sandrock

Weixiang Zhao

Shankar Sankaran

Michael Schivo

Richart Harper

Carol J Cardona

Zheng Xing

Cristina E Davis

Affiliations

Soon will be listed here.

Abstract

Volatile organic compounds (VOCs) emanating from humans have the potential to revolutionize non-invasive diagnostics. Yet, little is known about how these compounds are generated by complex biological systems, and even less is known about how these compounds are reflective of a particular physiological state. In this proof-of-concept study, we examined VOCs produced directly at the cellular level from B lymphoblastoid cells upon infection with three live influenza virus subtypes: H9N2 (avian), H6N2 (avian), and H1N1 (human). Using a single cell line helped to alleviate some of the complexity and variability when studying VOC production by an entire organism, and it allowed us to discern marked differences in VOC production upon infection of the cells. The patterns of VOCs produced in response to infection were unique for each virus subtype, while several other non-specific VOCs were produced after infections with all three strains. Also, there was a specific time course of VOC release post infection. Among emitted VOCs, production of esters and other oxygenated compounds was particularly notable, and these may be attributed to increased oxidative stress resulting from infection. Elucidating VOC signatures that result from the host cells response to infection may yield an avenue for non-invasive diagnostics and therapy of influenza and other viral infections.

Citing Articles

Zika virus modulates human fibroblasts to enhance transmission success in a controlled lab-setting.

Mozuraitis R, Cirksena K, Raftari M, Hajkazemian M, Mustapha Abiodun M, Brahimi J Commun Biol. 2025; 8(1):139.

PMID: 39885287 PMC: 11782651. DOI: 10.1038/s42003-025-07543-9.

Bioreactor contamination monitoring using off-gassed volatile organic compounds (VOCs).

Linderholm A, Bhandari M, Borras E, Kwon A, Herve F, McCartney M Anal Bioanal Chem. 2024; 417(6):1165-1176.

PMID: 39724424 DOI: 10.1007/s00216-024-05720-z.

Point-of-care breath sample analysis by semiconductor-based E-Nose technology discriminates non-infected subjects from SARS-CoV-2 pneumonia patients: a multi-analyst experiment.

Woehrle T, Pfeiffer F, Mandl M, Sobtzick W, Heitzer J, Krstova A MedComm (2020). 2024; 5(11):e726.

PMID: 39465142 PMC: 11502717. DOI: 10.1002/mco2.726.

High and low pathogenicity avian influenza virus discrimination and prediction based on volatile organic compounds signature by SIFT-MS: a proof-of-concept study.

Filaire F, Secula A, Bessiere P, Pages-Homs M, Guerin J, Violleau F Sci Rep. 2024; 14(1):17051.

PMID: 39048690 PMC: 11269574. DOI: 10.1038/s41598-024-67219-y.

A comprehensive meta-analysis and systematic review of breath analysis in detection of COVID-19 through Volatile organic compounds.

Long G, Xu Q, Sunkara J, Woodbury R, Brown K, Huang J Diagn Microbiol Infect Dis. 2024; 109(3):116309.

PMID: 38692202 PMC: 11405072. DOI: 10.1016/j.diagmicrobio.2024.116309.

References

SteelFisher G, Blendon R, Bekheit M, Lubell K . The public's response to the 2009 H1N1 influenza pandemic. N Engl J Med. 2010; 362(22):e65. DOI: 10.1056/NEJMp1005102. View

Rasanen I, Viinamaki J, Vuori E, Ojanpera I . Headspace in-tube extraction gas chromatography-mass spectrometry for the analysis of hydroxylic methyl-derivatized and volatile organic compounds in blood and urine. J Anal Toxicol. 2010; 34(3):113-21. DOI: 10.1093/jat/34.3.113. View

Takahashi Y, Onodera T, Kobayashi K, Kurosaki T . Primary and secondary B-cell responses to pulmonary virus infection. Infect Disord Drug Targets. 2012; 12(3):232-40. DOI: 10.2174/187152612800564400. View

Dalton P, Gelperin A, Preti G . Volatile metabolic monitoring of glycemic status in diabetes using electronic olfaction. Diabetes Technol Ther. 2004; 6(4):534-44. DOI: 10.1089/1520915041705992. View

Bouvier N, Palese P . The biology of influenza viruses. Vaccine. 2009; 26 Suppl 4:D49-53. PMC: 3074182. DOI: 10.1016/j.vaccine.2008.07.039. View

Erhart S, Amann A, Haberlandt E, Edlinger G, Schmid A, Filipiak W . 3-Heptanone as a potential new marker for valproic acid therapy. J Breath Res. 2011; 3(1):016004. DOI: 10.1088/1752-7155/3/1/016004. View

Rogers G, DSouza B . Receptor binding properties of human and animal H1 influenza virus isolates. Virology. 1989; 173(1):317-22. DOI: 10.1016/0042-6822(89)90249-3. View

Aksenov A, Gojova A, Zhao W, Morgan J, Sankaran S, Sandrock C . Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's "chemical odor fingerprint". Chembiochem. 2012; 13(7):1053-9. DOI: 10.1002/cbic.201200011. View

Choi Y, Baumgarth N . Dual role for B-1a cells in immunity to influenza virus infection. J Exp Med. 2008; 205(13):3053-64. PMC: 2605232. DOI: 10.1084/jem.20080979. View

10.

Baumgarth N, Choi Y, Rothaeusler K, Yang Y, Herzenberg L . B cell lineage contributions to antiviral host responses. Curr Top Microbiol Immunol. 2007; 319:41-61. DOI: 10.1007/978-3-540-73900-5_3. View

11.

Filipiak W, Sponring A, Baur M, Ager C, Filipiak A, Wiesenhofer H . Characterization of volatile metabolites taken up by or released from Streptococcus pneumoniae and Haemophilus influenzae by using GC-MS. Microbiology (Reading). 2012; 158(Pt 12):3044-3053. DOI: 10.1099/mic.0.062687-0. View

12.

Phillips M, Herrera J, Krishnan S, Zain M, Greenberg J, Cataneo R . Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl. 1999; 729(1-2):75-88. DOI: 10.1016/s0378-4347(99)00127-9. View

13.

Barash O, Peled N, Hirsch F, Haick H . Sniffing the unique "odor print" of non-small-cell lung cancer with gold nanoparticles. Small. 2009; 5(22):2618-24. PMC: 3368377. DOI: 10.1002/smll.200900937. View

14.

Zhu J, Bean H, Wargo M, Leclair L, Hill J . Detecting bacterial lung infections: in vivo evaluation of in vitro volatile fingerprints. J Breath Res. 2013; 7(1):016003. PMC: 4114336. DOI: 10.1088/1752-7155/7/1/016003. View

15.

Xing Z, Harper R, Anunciacion J, Yang Z, Gao W, Qu B . Host immune and apoptotic responses to avian influenza virus H9N2 in human tracheobronchial epithelial cells. Am J Respir Cell Mol Biol. 2010; 44(1):24-33. PMC: 3159084. DOI: 10.1165/rcmb.2009-0120OC. View

16.

HIRST G . THE QUANTITATIVE DETERMINATION OF INFLUENZA VIRUS AND ANTIBODIES BY MEANS OF RED CELL AGGLUTINATION. J Exp Med. 2009; 75(1):49-64. PMC: 2135212. DOI: 10.1084/jem.75.1.49. View

17.

Phillips M, Cataneo R, Condos R, Ring Erickson G, Greenberg J, La Bombardi V . Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb). 2006; 87(1):44-52. DOI: 10.1016/j.tube.2006.03.004. View

18.

Schwarz K . Oxidative stress during viral infection: a review. Free Radic Biol Med. 1996; 21(5):641-9. DOI: 10.1016/0891-5849(96)00131-1. View

19.

Chambers S, Bhandari S, Scott-Thomas A, Syhre M . Novel diagnostics: progress toward a breath test for invasive Aspergillus fumigatus. Med Mycol. 2010; 49 Suppl 1:S54-61. DOI: 10.3109/13693786.2010.508187. View

20.

Phillips M, Cataneo R, Greenberg J, Grodman R, Gunawardena R, Naidu A . Effect of oxygen on breath markers of oxidative stress. Eur Respir J. 2003; 21(1):48-51. DOI: 10.1183/09031936.02.00053402. View